The results revealed that quercetin and luteolin could activate the PI3K-Akt signaling pathway and inhibit liver fibrosis by binding to hub targets, including AKT1, CCND1, EGFR, MAPK1, MYC, and RELA. Here, MYC is linked to Hepatic fibrosis.